Nyxoah Q4 Earnings Call Highlights [Yahoo! Finance]
Nyxoah SA - Ordinary Shares (NYXH)
Company Research
Source: Yahoo! Finance
implants/revenue in Sept 2025); by Dec. 31 the company had trained 145 surgeons across 125 high-volume accounts and completed 120 VAC submissions with 57 approvals and no rejections. In Feb. 2026 CMS issued interim C-codes (C8011–C8013) for airway genioglossus nerve stimulation, with C8011 reimbursed in the hospital outpatient setting at , creating parity with competitors while surgeon billing is expected to continue under CPT 64582; Nyxoah expects dedicated AGNS CPT codes likely around 2028. Q4 2025 net revenue was EUR 5.6 million (up from EUR 1.3M YoY) with ~ EUR 3.5 million from the U.S. launch and full-year net revenue of EUR 10 million (+122% YoY); the company ended 2025 with EUR 48 million in cash, burning ~ EUR 20 million per quarter (runway into Q1 2027) and expects ~25% sequential U.S. revenue growth in Q1–Q2 2026 while expanding the U.S. salesforce to 40 reps. Interested in Nyxoah SA? Here are five stocks we like better. Nyxoah (NASDAQ:NYXH) used its fourth-quarter a
Show less
Read more
Impact Snapshot
Event Time:
NYXH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NYXH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NYXH alerts
High impacting Nyxoah SA - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
NYXH
News
- Nyxoah Reports Fourth Quarter and Full Year 2025 Financial and Operating ResultsGlobeNewswire
- Publication relating to transparency notificationGlobeNewswire
- Nyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services ConferenceGlobeNewswire
- Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026GlobeNewswire
- Nyxoah (NYXH) was upgraded by Cantor Fitzgerald to "strong-buy".MarketBeat
NYXH
Earnings
- 3/19/26 - Beat
NYXH
Sec Filings
- 3/19/26 - Form 6-K
- 1/30/26 - Form 6-K
- 1/14/26 - Form 6-K
- NYXH's page on the SEC website